nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
SEOM clinical guideline for secondary prevention (2019)
|
Santaballa, A. |
|
|
22 |
2 |
p. 187-192 |
artikel |
2 |
SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019)
|
Martín-Richard, M. |
|
|
22 |
2 |
p. 236-244 |
artikel |
3 |
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)
|
Majem, M. |
|
|
22 |
2 |
p. 213-222 |
artikel |
4 |
SEOM clinical guideline for treatment of kidney cancer (2019)
|
Lázaro, M. |
|
|
22 |
2 |
p. 256-269 |
artikel |
5 |
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
|
Muñoz Martín, A. J. |
|
|
22 |
2 |
p. 171-186 |
artikel |
6 |
SEOM clinical guideline on hereditary colorectal cancer (2019)
|
Guillén-Ponce, C. |
|
|
22 |
2 |
p. 201-212 |
artikel |
7 |
SEOM clinical guidelines for cervical cancer (2019)
|
de Juan, A. |
|
|
22 |
2 |
p. 270-278 |
artikel |
8 |
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)
|
Dómine, M. |
|
|
22 |
2 |
p. 245-255 |
artikel |
9 |
SEOM clinical guidelines in hereditary breast and ovarian cancer (2019)
|
González-Santiago, S. |
|
|
22 |
2 |
p. 193-200 |
artikel |
10 |
SEOM clinical guideline thyroid cancer (2019)
|
Gallardo, E. |
|
|
22 |
2 |
p. 223-235 |
artikel |
11 |
2019 SEOM guidelines (the end of a decade)
|
González-del-Alba, A. |
|
|
22 |
2 |
p. 169-170 |
artikel |